{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:52:36Z","timestamp":1793659956837,"version":"4.5.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NIH National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.neo.2026.101305","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:01:43Z","timestamp":1776078103000},"page":"101305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["PIK3CA mutant cervical cancer is selectively suppressed by PI3K\u03b1 inhibition (Alpelisib\/BYL-719 and Inavolisib\/GDC-0077) and cooperates with HPV directed T cell therapy"],"prefix":"10.1016","volume":"76","author":[{"given":"Hong","family":"Lou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Langan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4863-7575","authenticated-orcid":false,"given":"Nick","family":"Syracuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth A.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sojung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2150-8973","authenticated-orcid":false,"given":"Yi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7201-571X","authenticated-orcid":false,"given":"Sonam","family":"Tulsyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawnjerae","family":"Joe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Oberley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Oelke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2234-0631","authenticated-orcid":false,"given":"Michael","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neo.2026.101305_bib0001","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.neo.2026.101305_bib0002","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-immunol-031210-101324","article-title":"Natural innate and adaptive immunity to cancer","volume":"29","author":"Vesely","year":"2011","journal-title":"Annu. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.neo.2026.101305_bib0003","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/modpathol.2015.108","article-title":"Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers","volume":"28","author":"Mezache","year":"2015","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.neo.2026.101305_bib0004","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/modpathol.2016.221","article-title":"Expression of PD-L1 and presence of CD8-positive T cells in pre-treatment specimens of locally advanced cervical cancer","volume":"30","author":"Enwere","year":"2017","journal-title":"Mod. Pathol."},{"issue":"6230","key":"10.1016\/j.neo.2026.101305_bib0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.neo.2026.101305_bib0006","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1097-0215(19970717)72:2<313::AID-IJC19>3.0.CO;2-G","article-title":"Establishment and characterization of 12 uterine cervical-carcinoma cell lines: common sequence variation in the E7 gene of HPV-16-positive cell lines","volume":"72","author":"Ku","year":"1997","journal-title":"Int. J. Cancer"},{"issue":"7645","key":"10.1016\/j.neo.2026.101305_bib0007","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature21386","article-title":"Integrated genomic and molecular characterization of cervical cancer","volume":"543","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neo.2026.101305_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2022.01.003","article-title":"Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients","volume":"185","author":"Nguyen","year":"2022","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.neo.2026.101305_bib0009","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.neo.2026.101305_bib0010","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ajhg.2024.01.002","article-title":"Insights into the mechanisms and structure of breakage-fusion-bridge cycles in cervical cancer using long-read sequencing","volume":"111","author":"Rodriguez","year":"2024","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neo.2026.101305_bib0011","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-22-3030","article-title":"Extrachromosomal amplification of Human papillomavirus episomes is a mechanism of cervical carcinogenesis","author":"Rossi","year":"2023","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.neo.2026.101305_bib0012","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1158\/1078-0432.CCR-20-3286","article-title":"Clinical validation of a machine-learning-derived signature predictive of outcomes from first-line oxaliplatin-based chemotherapy in advanced colorectal cancer","volume":"27","author":"Abraham","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.neo.2026.101305_bib0013","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1038\/s41598-023-29550-8","article-title":"Transcriptome profiling for precision cancer medicine using shallow nanopore cDNA sequencing","volume":"13","author":"Mock","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neo.2026.101305_bib0014","first-page":"7","article-title":"The Human TET2 gene contains three distinct promoter regions with differing tissue and developmental specificities","author":"Lou","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neo.2026.101305_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1070529","article-title":"AIM platform: a new immunotherapy approach for viral diseases","volume":"9","author":"Langan","year":"2022","journal-title":"Front. Med."},{"issue":"13","key":"10.1016\/j.neo.2026.101305_bib0016","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1158\/1078-0432.CCR-19-3487","article-title":"Rapid expansion of highly functional antigen-specific T cells from patients with melanoma by Nanoscale artificial antigen-presenting cells","volume":"26","author":"Ichikawa","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.neo.2026.101305_bib0017","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s12276-020-00492-9","article-title":"The potential role of YAP in head and neck squamous cell carcinoma","volume":"52","author":"Shin","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"13","key":"10.1016\/j.neo.2026.101305_bib0018","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1200\/JCO.2017.72.7107","article-title":"Phosphatidylinositol 3-kinase alpha-selective inhibition with Alpelisib (BYL719) in PIK3CA-altered solid tumors: results from the first-in-Human study","volume":"36","author":"Juric","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.neo.2026.101305_bib0019","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/03008916211073621","article-title":"BYL719 (alpelisib) for the treatment of PIK3CA-mutated, recurrent\/advanced cervical cancer","volume":"109","author":"Bogani","year":"2023","journal-title":"Tumori"},{"issue":"3","key":"10.1016\/j.neo.2026.101305_bib0020","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28656","article-title":"Genomic analysis of cervical carcinoma identifies Alpelisib as a therapeutic option for PIK3CA-mutant cervical carcinoma via the PI3K\/AKT pathway","volume":"95","author":"Wei","year":"2023","journal-title":"J. Med. Virol."},{"issue":"3","key":"10.1016\/j.neo.2026.101305_bib0021","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/imm.13682","article-title":"Targeting PI3Kalpha increases the efficacy of anti-PD-1 antibody in cervical cancer","volume":"170","author":"Jiang","year":"2023","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.neo.2026.101305_bib0022","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.neo.2026.101305_bib0023","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell. Rep."},{"key":"10.1016\/j.neo.2026.101305_bib0024","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3389\/fimmu.2017.00689","article-title":"Cervical cancer neoantigen landscape and immune activity is associated with Human papillomavirus master regulators","volume":"8","author":"Qin","year":"2017","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.neo.2026.101305_bib0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13045-016-0341-7","article-title":"PD-L1 is upregulated by EBV-driven LMP1 through NF-kappaB pathway and correlates with poor prognosis in natural killer\/T-cell lymphoma","volume":"9","author":"Bi","year":"2016","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.neo.2026.101305_bib0026","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/abbs\/gmu110","article-title":"The regulation and function of YAP transcription co-activator","volume":"47","author":"Zhu","year":"2015","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"6","key":"10.1016\/j.neo.2026.101305_bib0027","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.celrep.2014.05.012","article-title":"APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development","volume":"7","author":"Henderson","year":"2014","journal-title":"Cell Rep."},{"issue":"23","key":"10.1016\/j.neo.2026.101305_bib0028","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1158\/1078-0432.CCR-14-1837","article-title":"Genome analysis of Latin American cervical cancer: frequent activation of the PIK3CA pathway","volume":"21","author":"Lou","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"7488","key":"10.1016\/j.neo.2026.101305_bib0029","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature12881","article-title":"Landscape of genomic alterations in cervical carcinomas","volume":"506","author":"Ojesina","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.neo.2026.101305_bib0030","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1158\/1535-7163.MCT-13-0865","article-title":"Characterization of the novel and specific PI3Kalpha inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials","volume":"13","author":"Fritsch","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.neo.2026.101305_bib0031","first-page":"3240","article-title":"Alpelisib and radiotherapy treatment enhances Alisertib-mediated cervical cancer tumor killing","volume":"11","author":"Tayyar","year":"2021","journal-title":"Am. J. Cancer Res."},{"issue":"20","key":"10.1016\/j.neo.2026.101305_bib0032","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.neo.2026.101305_bib0033","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJMoa2112187","article-title":"Survival with Cemiplimab in recurrent cervical cancer","volume":"386","author":"Tewari","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neo.2026.101305_bib0034","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-01225-1","article-title":"TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers","author":"Nagarsheth","year":"2021","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.neo.2026.101305_bib0035","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13046-023-02704-2","article-title":"New insights into the ambivalent role of YAP\/TAZ in human cancers","volume":"42","author":"Luo","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.neo.2026.101305_bib0036","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/0008-5472.CAN-17-2118","article-title":"E6 Protein expressed by high-risk HPV activates super-enhancers of the EGFR and c-MET oncogenes by destabilizing the histone demethylase KDM5C","volume":"78","author":"Chen","year":"2018","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.neo.2026.101305_bib0037","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.1038\/s41467-022-34559-0","article-title":"Pharmacological blockade of TEAD-YAP reveals its therapeutic limitation in cancer cells","volume":"13","author":"Sun","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neo.2026.101305_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073393","article-title":"MIAT Is an Upstream Regulator of NMYC and the Disruption of the MIAT\/NMYC Axis Induces Cell Death in NMYC Amplified Neuroblastoma Cell Lines","volume":"22","author":"Feriancikova","year":"2021","journal-title":"Int J Mol Sci"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:29:58Z","timestamp":1776814198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558626000345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"alternative-id":["S1476558626000345"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2026.101305","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PIK3CA mutant cervical cancer is selectively suppressed by PI3K\u03b1 inhibition (Alpelisib\/BYL-719 and Inavolisib\/GDC-0077) and cooperates with HPV directed T cell therapy","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2026.101305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101305"}}